Ctt Pharmaceutical Holdings Inc
CTTHOfficial IPO
Filed· OTC· Listing market: United StatesSources: lifecycle-news, sec-edgar, sec-harvest
No live market is quoted for Ctt Pharmaceutical Holdings Inc yet. Get in line for IPO-day access through a broker in the meantime.
Invest in stocks once they list with eToro
Trade stocks, ETFs and crypto from one simple account.
Financials
UnprofitableFrom SEC filings, latest FY ending Dec 31, 2014 · CIK 0001035422.
| Metric | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|
| Operating income | -$672.16K | -$18.91K | -$1.19M | -$757.94K | -$2.07M |
| Net income | -$672.16K | -$18.91K | -$1M | $3.74M | -$1.1M |
| Cash & equivalents | $81.18K | $823 | $12.09K | $569.38K | $46.19K |
| Total assets | $1.66M | $6.25K | $203.08K | $4.18M | $1.26M |
| Total liabilities | $169.49K | $29.32K | $589.41K | $3.73M | $1.26M |
| Shareholders' equity | $1.49M | -$29.32K | -$20K | $456.45K | $1.35K |
About Ctt Pharmaceutical Holdings Inc
Ctt Pharmaceutical Holdings Inc is The drug delivery industry develops technologies for the improved administration of drugs.
What the company does
- Drug delivery companies may seek to develop products on their own that would be patent-protected by applying proprietary technologies to off-patent pharmaceutical products.
- Primarily, drug delivery technologies are focused on improving safety, efficacy, ease of patient use and/or patient compliance.
- Pharmaceutical and biotechnology companies consider improved drug delivery as a means of gaining competitive advantage over their peers...
Business profile
Ctt Pharmaceutical Holdings Inc belongs to the healthcare and life-sciences market, where product evidence, regulatory pathways, customer adoption, and funding discipline shape long-term outcomes.
SEC IPO filings
AmendedEDGAR filings resolved from CTTH / CIK 0001035422.
Latest Ctt Pharmaceutical Holdings Inc IPO news
Recent sourced articles classified for IPO relevance, with platform-access noise filtered out where possible.
CTT Pharmaceutical Holdings, Inc. filed an S-1/A on May 29, 2026 for resale of up to 6,250,000 shares of common stock held by RH2 Equity Partners in connection with its equity line of credit (ELOC), with the prospectus discussing fluctuating purchase-price mechanics based on market prices.
Ctt Pharmaceutical Holdings Inc IPO — frequently asked questions
- When is Ctt Pharmaceutical Holdings Inc's IPO?
- Ctt Pharmaceutical Holdings Inc has not announced an official IPO date yet — it is still privately held. We update this page as soon as an IPO date, filing or price range is reported.
- What is Ctt Pharmaceutical Holdings Inc's expected IPO price?
- Ctt Pharmaceutical Holdings Inc's IPO price has not been set yet. The price range is usually disclosed in the final prospectus, shortly before the company lists.
- Is Ctt Pharmaceutical Holdings Inc publicly traded?
- Not yet — Ctt Pharmaceutical Holdings Inc is still a private company, so its shares aren't available on public exchanges. IPO Tracker monitors pre-IPO markets, IPO filings and the IPO calendar, so Ctt Pharmaceutical Holdings Inc's pre-IPO price and IPO date will appear here as soon as they're available.